BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3433308)

  • 1. A rapid and safe procedure for preparing the murine toxins of the plague bacillus (Yersinia pestis).
    Seguin MC; Harrison DN; Williams JE
    Toxicon; 1987; 25(9):989-94. PubMed ID: 3433308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The activation of Yersinia pestis "murine" toxin and endotoxin by hemolyzed erythrocytes from mammalian blood].
    Tynianova VI; Demidova GV; Ziuzina VP; Bespalova IA; Kubantseva EP; Goncharov EK; Pasiukova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):16-8. PubMed ID: 8525723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine toxin of Yersinia pestis shows phospholipase D activity but is not required for virulence in mice.
    Hinnebusch J; Cherepanov P; Du Y; Rudolph A; Dixon JD; Schwan T; Forsberg A
    Int J Med Microbiol; 2000 Oct; 290(4-5):483-7. PubMed ID: 11111930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural and functional properties and the biological activity of Yersinia pestis capsular antigen, murine toxin and endotoxin].
    Isin ZhM; Tugambaev TI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):91-8. PubMed ID: 3300112
    [No Abstract]   [Full Text] [Related]  

  • 6. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis.
    Drozdov IG; Anisimov AP; Samoilova SV; Yezhov IN; Yeremin SA; Karlyshev AV; Krasilnikova VM; Kravchenko VI
    J Med Microbiol; 1995 Apr; 42(4):264-8. PubMed ID: 7707334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector.
    Hinnebusch BJ; Rudolph AE; Cherepanov P; Dixon JE; Schwan TG; Forsberg A
    Science; 2002 Apr; 296(5568):733-5. PubMed ID: 11976454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples.
    Hsu HL; Chuang CC; Liang CC; Chiao DJ; Wu HL; Wu YP; Lin FP; Shyu RH
    BMC Infect Dis; 2018 Aug; 18(1):402. PubMed ID: 30107826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant murine toxin from Yersinia pestis shows high toxicity and β-adrenergic blocking activity in mice.
    Fan Y; Zhou Y; Feng N; Wang Q; Tian G; Wu X; Liu Z; Bi Y; Yang R; Wang X
    Microbes Infect; 2016 May; 18(5):329-35. PubMed ID: 26774329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic activity of the "murine" toxin of the plague microbe in experiments on animals].
    Evstigneev VI; Chicherin IuV; Byvalov AA; Pautov VN; Dodonov NP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):39-42. PubMed ID: 7245966
    [No Abstract]   [Full Text] [Related]  

  • 11. [The capacity of Yersinia pestis toxin to decrease the functional response of human thrombocytes to stimulation by hormones].
    Cherkasova TD; Bochkov VN; Iurkiv VA; Pokrovskiĭ VI
    Biull Eksp Biol Med; 1993 Nov; 116(11):529-32. PubMed ID: 8312552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Purification and characterization of hec toxin produced by Aeromonas hydrophila].
    Tu X; Lin C
    Wei Sheng Wu Xue Bao; 1992 Dec; 32(6):432-8. PubMed ID: 1299032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thermostable Yersinia pseudotuberculosis toxin: its isolation, purification and the characteristics of its properties].
    Nedashkovskaia EP; Timchenko NF; Besednov AL; Vertiev IuV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):5-9. PubMed ID: 9381872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levels of prostaglandin E1 and F2 alpha in the dynamics of toxic-infectious shock induced by Yersinia pestis].
    Cherkasova TD; Vengrov PR; Melikhov VI; Avrorov VP; Iurkiv VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):313-5. PubMed ID: 3162386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis).
    Williams JE; Cavanaugh DC
    Experientia; 1984 Jul; 40(7):739-40. PubMed ID: 6745406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.
    Ponnusamy D; Fitts EC; Sha J; Erova TE; Kozlova EV; Kirtley ML; Tiner BL; Andersson JA; Chopra AK
    Infect Immun; 2015 May; 83(5):2065-81. PubMed ID: 25754198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialoglycan-binding patterns of bacterial AB
    Khan N; Sasmal A; Khedri Z; Secrest P; Verhagen A; Srivastava S; Varki N; Chen X; Yu H; Beddoe T; Paton AW; Paton JC; Varki A
    J Biol Chem; 2022 May; 298(5):101900. PubMed ID: 35398357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.